primary systemic amyloidosis

Showing 1 - 14 of 14

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,

Active, not recruiting
  • Light Chain Deposition Disease
  • Primary Systemic Amyloidosis
  • Denver, Colorado
  • +4 more
Jan 20, 2023

Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)

Active, not recruiting
  • Primary Systemic Amyloidosis
  • Light Chain Deposition Disease
  • Denver, Colorado
  • +6 more
Aug 24, 2022

Amorphous, Eosinophilic, and Acellular Deposit, Constipation, Diarrhea Trial in United States (Isatuximab, Laboratory Biomarker

Active, not recruiting
  • Amorphous, Eosinophilic, and Acellular Deposit
  • +12 more
  • Isatuximab
  • Laboratory Biomarker Analysis
  • Anchorage, Alaska
  • +344 more
Aug 22, 2022

Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in United States (melphalan, dexamethasone, bortezomib)

Completed
  • Light Chain Deposition Disease
  • Primary Systemic Amyloidosis
  • Scottsdale, Arizona
  • +208 more
Jan 12, 2022

Primary Systemic Amyloidosis Trial in Milwaukee (Doxycycline)

Completed
  • Primary Systemic Amyloidosis
  • Milwaukee, Wisconsin
    Froedtert & Medical College of Wisconsin
Jun 18, 2021

Acute Undifferentiated Leukemia, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma Trial in

Completed
  • Acute Undifferentiated Leukemia
  • +63 more
  • total-body irradiation
  • +7 more
  • Seattle, Washington
  • +1 more
Jan 17, 2020

Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic

Completed
  • Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
  • +76 more
  • fludarabine phosphate
  • +6 more
  • Tucson, Arizona
  • +10 more
Jan 17, 2020

Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +178 more
  • fludarabine phosphate
  • +5 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Apr 17, 2017

Primary Systemic Amyloidosis Trial in Spain (Lenalidomide, Cyclophosphamide, Dexamethasone)

Completed
  • Primary Systemic Amyloidosis
  • Tenerife, Islas Canarias, Spain
  • +9 more
Apr 23, 2017

Primary Systemic Amyloidosis Trial in Rochester (bortezomib, cyclophosphamide, dexamethasone)

Completed
  • Primary Systemic Amyloidosis
  • Rochester, Minnesota
    Mayo Clinic
Mar 5, 2014

Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +84 more
  • sunitinib malate
  • +2 more
  • Los Angeles, California
  • +10 more
Mar 14, 2014

Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, AIDS-related Peripheral/Systemic Lymphoma Trial

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +80 more
  • imatinib mesylate
  • pharmacological study
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Feb 6, 2013

Primary Systemic Amyloidosis Trial in Rochester (4'-iodo-4'-deoxydoxorubicin, pharmacological study)

Terminated
  • Primary Systemic Amyloidosis
  • Rochester, Minnesota
    Mayo Clinic
Jan 15, 2013

Primary Systemic Amyloidosis Trial (Enbrel)

Suspended
  • Primary Systemic Amyloidosis
  • (no location specified)
Sep 21, 2005